The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 51 | — | 20.1x | Near average | |
Growth | 8 | — | 5.6% | Below average | |
Quality | 12 | -75.7% | 7.6% | Below average | |
Safety | 53 | 0.3x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Viking Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Viking Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
VKTX stock has seen a slight bearish revision in its average price target over the last 30 days, with the consensus dropping from 98.67 to 93.6 dollars (-5.14%). This decline coincided with two new analysts initiating coverage on the stock, bringing the total number of analysts to 15. Despite the decrease in the average, Analyst Dispersion remains confined within a relatively narrow range between 83 and 101 dollars, reflecting a general agreement on fair value despite recent adjustments.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.